Registration
Online Registration is Open!
Member Log-In
Co-Located Event
Accreditation
Speakers
Speakers
| Jeff Shuren, MD, Director, Center for Devices and Radiological Health at the FDA |
| Marcia Gelber, Pharmacist, Division of Compliance Risk Management and Surveillance, Surveillance and Data Analysis Branch, Office of Compliance, CDER, FDA |
| Carl L. Alden, DVM, Vice President, Drug Safety Evaluation, MILLENNIUM PHARMACEUTICALS |
| Andrew Bate, PhD, MA, Senior Director, Analytics Team Lead, Epidemiology, Worldwide Safety Strategy, PFIZER, INC. |
| David Brown, PhD, MPH, MA, Executive Director of Epidemiology, PPD, INC. |
| Elliot G. Brown, MB, ChB, BMedSci, MRCGP, FFPM, Managing Director, ELLIOT BROWN CONSULTING LTD., Director, PRIMEVIGILANCE LTD. |
| Terry Crowley, RN, MS, Senior Director, Pharmacovigilance, SUNESIS PHARMACEUTICALS, INC. |
| Brian Edwards, MB MD, MRCP, Scientific Advisor, Pharmacovigilance and Drug Safety, NDA REGULATORY SCIENCE LIMITED, UK |
| A. Leander Fontaine, MD, PhD, President, PHARMICEUTICS LLC |
| Stephen A. Goldman, MD, FAPM, DFAPA, Managing Member, STEPHEN A. GOLDMAN CONSULTING SERVICES, LLC, Former Medical Director, MEDWATCH, FDA |
| Mike Klepper, MD, President, MICHAEL J. KLEPPER, MD, LLC |
| Elizabeth Luczak, Global Head, SRM Quality Safety Alliances, PFIZER INC |
| Mark T. Marino, MD, Vice President, Early Clinical Development, MANNKIND CORPORATION |
| L. Paul Starkey, MD, FAAFP, Executive Director, Medical Affairs-Americas, PRA INTERNATIONAL |
| Phil J. Weatherill, BSc (Hons), PhD, Global Head of Pharmacovigilance, EU Qualified Person for Pharmacovigilance, IPSEN, UK |
| Shinya Yamauchi, Operating Officer, OTSUKA PHARMACEUTICAL CO., LTD |
| MariaGrazia Zurlo, MD, VP, Worldwide Safety Strategy, EU Qualified Person for Pharmacovigilance, PFIZER, ITALY |